Replies to post #11622 on NanoLogix Inc (NNLX)

[leroy kelly]

These are not big hurdles but are facts.

This is how it is done and imo is what James Rodgers brings to the table.

This is how these Diagnostic companies grow their profits by partnering with great technology.

If you are an investor then you would already know this.

GLTAL

[Down_Home_Texan]

That's some pretty old straw you're using to make an argument.

You know, and as others have pointed out, that a lot has changed since that article was written back in February.

You have, inadvertently I'm sure, demonstrated that Bret is a person of character. In the article he states that Covid 19 will be a hot issue but NNLX was in no position to participate.

Bret was being honest and realistic.

February is long gone and new exciting things are happening.

Bret now believes NNLX has something to offer in the fight against Covid 19.

I believe Bret is still being honest and realistic.

DownHomeTexan

[exploremore]

"based upon preliminary development work done for detection of proteins associated with Ebola in 2014',"
" it may not be viewed as worthwhile in a cost:benefit analysis by various agencies or institutions."

As far as I know there is as little known about the Ebola test as there is about the covid test. Is the covid test is based on the same idea? If that is the case the statement, "it may not be viewed as worthwhile", would seem to stem from what was learned during the preliminary development work on Ebola.

Did they not follow up simply because Ebola faded out or it was found to be viewed to be not worthwhile.

I hear the covid test to be released is 100% accurate on the MBs. What has NNLX claimed?